Figure 6.
Figure 6. Ex vivo–expanded BM HSCs are CD62L-, IGF2-hFc+, CD31+, Tie-2-, and prominin-1-. After 10 days of culture of total BM cells, 4 × 104 sorted CD62L+ and CD62L- cells, or IGF2-hFc+ and IGF2-hFc- cells, or Mpl+ and Mpl- cells, or CD31+ and CD31- cells, or 6000 sorted Tie-2+ and Tie-2- cells, or 6000 prominin-1+ and prominin-1- cells were transplanted, respectively, together with 105 CD45.1 competitor cells into lethally irradiated CD45.1 mice (n = 4). Peripheral blood engraftments at 4 months after transplantation are shown. Error bars indicate SEM.

Ex vivo–expanded BM HSCs are CD62L-, IGF2-hFc+, CD31+, Tie-2-, and prominin-1-. After 10 days of culture of total BM cells, 4 × 104 sorted CD62L+ and CD62L- cells, or IGF2-hFc+ and IGF2-hFc- cells, or Mpl+ and Mpl- cells, or CD31+ and CD31- cells, or 6000 sorted Tie-2+ and Tie-2- cells, or 6000 prominin-1+ and prominin-1- cells were transplanted, respectively, together with 105 CD45.1 competitor cells into lethally irradiated CD45.1 mice (n = 4). Peripheral blood engraftments at 4 months after transplantation are shown. Error bars indicate SEM.

Close Modal

or Create an Account

Close Modal
Close Modal